General Science

General Science Experts

Ignace Lasters

Chief Technology Officer


Ignace Lasters has more than 20 years of experience in the life science industry. He has published over 60 internationally peer-reviewed articles and is named inventor on numerous patent applications. His research experience involves various aspects of biochemistry, physic-chemistry and computer modeling techniques applied to protein engineering and drug discovery. Ignace holds a PhD in Biochemistry from the Free University of Brussels (1980). He joined the biotech industry in 1986, as head of the Computer Modeling Group in the Protein Engineering Division of PGS (now Bayer CropSciences, Ghent, Belgium), where he focused on the development of 3D modeling software to improve the functional properties of industrial enzymes. In 1991 he joined Corvas International (now Dendreon, WA, USA) and headed up a team that discovered novel anti-thrombotics based on inhibitors of enzymes in the blood coagulation cascade. In 1995 he went back to academia and spent two years at the University of Leuven (Belgium), in the laboratory of Professor Desiré Collen, the inventor of t-PA and founder of ThromboGenics. Thereafter, from 1997 onwards he worked as an independent consultant for various companies, including Innogenetics, Keygene and Genscope, focusing on structural bioinformatics, biostatistics and advanced scientific programming applications. In 1999, Ignace co-founded Algonomics, a bioinformatics company dedicated to immunogenicity analysis and antibody engineering, and acted as its CEO/CSO until 2008, when Algonomics was acquired by Lonza. In 2008 Ignace co-founded Complix and became its first CEO. From June 2010 Ignace assumed the roles of CSO and, more recently, CTO at Complix.

Research Interest


Global Experts from Austria

Global Experts in Subject